Contact this trialFirst, we need to learn more about you.
Immunomodulator
IMCY-0098 for Type 1 Diabetes
Recruiting0 awardsPhase 2
Boston, Massachusetts
This trial is studying a new experimental drug to see if it can stop the body's immune system from attacking and destroying the insulin-producing cells in people with type 1 diabetes.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.